Neurotechnology & The Law: Contract Law – Harry Lambert published in the New Law Journal

Harry Lambert has co-authored an article alongside Dr Michelle Sharpe in the New Law Journal’s latest feature, titled ‘Neurotechnology & The Law: Contract Law’.

Consumer neurotech devices that read and respond to brain and nerve activity are commercially available. A brain–computer interface (BCI) can be used to make purchases, confirm in-app transactions, and interact with online marketplaces. This has the potential to radically reshape how contracts are formed and enforced in the digital marketplace. In this article, Harry and Dr Michelle set out how neurotech presents new ways to evidence contractual consent, and new ways to erode it.

The article highlights the following:

• How neurotechnology may inform consent;
• How neurotechnology may subvert consent
• Regulatory frameworks & industry standards

‘Neurotechnology & The Law: Contract Law’

Read the full article here. Non-subscribers may access the article free of charge by filling in a short verification form.

About the author

Harry Lambert specialises in the areas of product liability, medical tech, clinical negligence, personal injury, and human rights law. He is also renowned for his expertise in group litigation claims relating to these areas.

Harry is a creative and inventive lawyer, at the forefront of thought leadership on issues of product liability in the digital age. He is also the Founder and Head of the Centre for Neurotechnology & Law, and his 12-part series on Neurotechnology and The Law has garnered academic acclaim, been translated into several European languages, and turned into a podcast run by the Italian equivalent of the Financial Times.

To find out more about Harry, contact Paul Barton on +44 (0)20 7427 4907 or Harry Gamble on +44 (0)20 7353 6381 for a confidential discussion.

External Publications, News 22 Jan, 2026